Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Control of Blood Pressure and Risk Attenuation-Bangladesh, Pakistan and Sri Lanka (COBRA-BPS)

NCT02657746 is registered in ClinicalTrials.gov with Duke-NUS Graduate Medical School as lead sponsor.

NCT NCT02657746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02657746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Control of Blood Pressure and Risk Attenuation-Bangladesh, Pakistan and Sri Lanka (COBRA-BPS)
Lead sponsor
Duke-NUS Graduate Medical School
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2016
Completion date
March 31, 2020
Enrollment
2,550 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension